John M. Dineen
Director, MERRIMACK PHARMACEUTICALS INC.
Companies
- Lam ResearchBoard member Aug 25, 2023 to now1
- Cognizant Technology SolutionsBoard member Apr 4, 2017 to now2
- Syneos Health, Inc.Board member Dec 11, 2018 to Sep 28, 20233
- MERRIMACK PHARMACEUTICALS INCBoard member Jun 16, 2015 to Jun 15, 20184
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Lam Research LRCX9,135 shares5$2.4M at $264.15Nov 7, 2025Cognizant Technology Solutions CTSH1,827 shares6$120.9K at $66.17Nov 13, 2023
- Syneos Health, Inc.0 shares7Sep 28, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Nov 7, 2025Granted 1,635 shares of Lam Research5
- Nov 8, 2024Granted 2,950 shares of Lam Research8
- Nov 13, 2023Exercised options 1,827 shares at $59.52 of Cognizant Technology Solutions6
- Nov 10, 2023Granted 369 shares of Lam Research9
- Nov 10, 2023Granted 86 shares of Lam Research9
- Sep 28, 2023Returned to company 4,863 shares of Syneos Health, Inc.7
- Sep 28, 2023Returned to company 22,629 shares at $43.00 of Syneos Health, Inc.7
- May 25, 2023Granted 4,863 shares of Syneos Health, Inc.10
- May 25, 2022Granted 2,839 shares of Syneos Health, Inc.11
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARLam Research, Board member
- 2
- 3SEC EDGARSyneos Health, Inc., Board member
- 4
- 5
- 6
- 7
- 8SEC EDGARForm 4 filed Nov 12, 2024
- 9SEC EDGARForm 4 filed Nov 13, 2023
- 10SEC EDGARForm 4 filed May 30, 2023
- 11SEC EDGARForm 4 filed May 27, 2022